Terumo acquires Essen Technology to enter drug-eluting stent market in China

Terumo Corporation has agreed to acquire Essen Technology (Beijing) Co., Ltd., a Chinese medical device company specializing in drug-eluting stents. The upfront payment is 879 million Chinese Yuan, with milestone payments based on future performance.

“The product lineups of the two companies are highly complementary, and the importance of domestic products in China is increasing.”terumois.com

• 1 source
• terumois.comTerumo Acquires China-based Essen Technology To Enter Drug-eluting Stent Market in China | Terumo Interventional SystemsJul 24, 2018

Summarized from public sources; check the original articles before acting on it.